Pearson Pharma Partners
Westlake Village, CA
- UEI
- TJN3M3UNJF15
- CAGE
- 6EHY7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 823 Pleasant Dale Pl, Westlake Village, CA 91362, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Subject matter expert consultant for drug metabolism pharmacokinetics [dmpk]. | National Institute on Drug Abuse | $184,000 | |
| Subject matter expert consultant for drug metabolism pharmacokinetics [dmpk]. | National Institute on Drug Abuse | $330,000 | |
| Dmpk consulting support services | National Institute on Drug Abuse | $61,600 | |
| Pearson pharma partners:1198214 [16-004009] | National Institute on Drug Abuse | $11,600 | |
| NIH drug development consulting services | National Institute on Drug Abuse | $173,268 |
About Pearson Pharma Partners
Pearson Pharma Partners is a for-profit S Corporation based in Westlake Village, California, specializing in pharmaceutical consulting services, specifically in the domain of Drug Metabolism and Pharmacokinetics (DMPK). Registered in the System for Award Management (SAM.gov) since June 2011, the company provides subject matter expert consulting services to federal agencies, with a particular focus on supporting neuroscience research initiatives. The firm's expertise appears centered on providing high-level scientific consulting to national research institutions, leveraging deep technical knowledge in pharmacological research and development.
The company has secured multiple federal contract awards from prominent National Institutes of Health (NIH) agencies, specifically the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute on Drug Abuse (NIDA). These contracts, ranging from $24,000 to $532,500, are primarily purchase order agreements for DMPK consulting support services. Two of the three contracts were set aside for small businesses, indicating the company's status as a small business enterprise. The contracts involve providing senior-level DMPK consultants who advise on study design, data analysis, and project milestones for the Blueprint Neurotherapeutics Program and other neuroscience initiatives. The consulting work is predominantly performed remotely, with occasional travel to NIH facilities in Bethesda, Maryland, and focuses on supporting the development of new treatments for neurological disorders through expert scientific guidance.
Quick answers
What is Pearson Pharma Partners's UEI?
Pearson Pharma Partners's Unique Entity ID (UEI) in SAM.gov is TJN3M3UNJF15.
What is Pearson Pharma Partners's CAGE code?
Pearson Pharma Partners's CAGE code is 6EHY7.
What is Pearson Pharma Partners's primary NAICS code?
Pearson Pharma Partners's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Pearson Pharma Partners located?
Pearson Pharma Partners's physical address in SAM.gov is 823 Pleasant Dale Pl, Westlake Village, CA 91362, USA.
Is Pearson Pharma Partners registered in SAM.gov?
Yes. Pearson Pharma Partners's SAM.gov registration is active through June 27, 2027.
What is Pearson Pharma Partners's most recent federal award?
Pearson Pharma Partners's most recent federal contract award is Subject matter expert consultant for drug metabolism pharmacokinetics [dmpk] (75N95025P00418), from National Institute on Drug Abuse, on September 18, 2025.
On GovTribe
See Pearson Pharma Partners's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors